Standard heparin, low molecular weight heparin, low molecular weight heparinoid, and recombinant hirudin differ in their ability to inhibit transduction by recombinant adeno-associated virus type 2 vectors

Gene Therapy

Volumn 8, Issue 12, 2001, Pages 966-968

  Hacker, U T ^a,b   Gerner, F M ^a,b   Buning H ^a   Hutter, M ^a   Reichenspurner, H ^b   Stangl, M ^b   Hallek, M ^a,b,c  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Adeno associated virus type 2; Anticoagulants; Gene transfer; Heparin; Inhibition

Indexed keywords

ANTICOAGULANT AGENT; DANAPAROID; HEPARAN SULFATE; HEPARIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; ORGANAN; PROTEOGLYCAN; RECOMBINANT HIRUDIN; TINZAPARIN; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ARTICLE; CARDIOVASCULAR SYSTEM; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; THROMBOSIS; VIRUS RECOMBINANT;

ANTICOAGULANTS; CHONDROITIN SULFATES; DEPENDOVIRUS; DERMATAN SULFATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; GENETIC VECTORS; HELA CELLS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HEPARITIN SULFATE; HIRUDINS; HUMANS; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC;

EID: 0034957281     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301466     Document Type: Article

References (23)

1. Recombinant adeno-associated virus (rAAV) vectors for somatic gene therapy: Recent advances and potential clinical applications
2. Differential and persistent expression patterns of CNC gene transfer by an adeno-associated virus / AAV vector
3. Efficient long term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
4. Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice
5. AAV vectors: Is clinical success on the horizon?
6. Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia
7. Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors
8. High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors
9. Recombinant adeno-associated virus for the generation of autologous, gene-modified tumor vaccines: Evidence for a high transduction efficiency into primary epithelial cancer cells
10. Adeno-associated virus vectors for vascular gene delivery
11. Adeno-associated virus-mediated gene transfer into rat carotid arteries
12. Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors
13. The interaction of heparan sulfate and adeno-associated virus 2
14. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions
15. Catheter-mediated VEGF gene transfer to human coronary arteries after angioplasty. Safety results from phase I Kupio angioplasty gene transfer trail (KAT trial)
16. Ex vivo gene therapy of human vascular bypass grafts with E2F decoy: The PREVENT single-centre, randomized controlled trial
17. Optimizing cardiovascular gene therapy: Increased vascular gene transfer with modified adenoviral vectors
18. Heparin
19. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism
20. Danaparoid in the prevention of thromboembolic complications
21. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia
22. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus
23. Genetic capsid modifications allow efficient retargeting of adeno-associated virus type 2